Azstarys is a medicine used to treat ADHD in kids 6 and older, teens and adults. It is taken as a capsule once a day. It works by raising levels of brain chemicals that help with focus and self-control, with part of the dose starting fast and part working later in the day.
Every report comes from a Lived member, sent anonymously.
Have you tried Azstarys (Serdexmethylphenidate / Dexmethylphenidate) for ADHD?
Azstarys is a once-daily stimulant medicine for attention deficit hyperactivity disorder (ADHD) in children 6 and older, teenagers and adults. ADHD makes it harder to sustain attention, organize tasks and hold back impulses, and stimulant medicines are one of the main treatments that reduce these symptoms day to day. The capsule contains two ingredients. Dexmethylphenidate is the more active form of methylphenidate, a long-established ADHD medicine. Serdexmethylphenidate is a prodrug: an inactive form that the body gradually converts into dexmethylphenidate. Combining the two is meant to give symptom control that starts in the morning and lasts into the evening from a single dose. Azstarys is not recommended for children under 6, who absorbed more of the drug and had more side effects, such as weight loss, in studies. It is usually prescribed as part of a broader plan that can include behavioral strategies, school or workplace support, and therapy.
Dopamine and norepinephrine are chemical messengers that help the brain's attention and self-control networks work. After nerve cells release them, these messengers are normally pulled back into the cell that sent them. Dexmethylphenidate blocks that recapture and increases their release, so more of each remains available to carry signals. Exactly why this reduces ADHD symptoms is still not fully understood. The two ingredients act on different timelines. The dexmethylphenidate portion is absorbed quickly and starts working early. Serdexmethylphenidate does little on its own; it is converted into dexmethylphenidate mainly in the lower part of the gut, releasing more active drug over the following hours. In a study of children 6 to 12, the effect was measurable from about 30 minutes to 13 hours after a morning dose.
Azstarys is taken by mouth once a day in the morning, with or without food. It comes in three capsule strengths, each labeled with two numbers: the amount of serdexmethylphenidate and the amount of dexmethylphenidate (for example, 39.2 mg/7.8 mg). Most people start at the middle strength, and the prescriber adjusts it after a week depending on how well it works and how it is tolerated. The capsule can be swallowed whole or opened and the full contents sprinkled over about two tablespoons of applesauce or stirred into a small amount of water. The mixture should be taken right away, within 10 minutes, rather than saved for later. This makes it an option for people who have trouble swallowing pills. Azstarys is not interchangeable milligram for milligram with other methylphenidate products such as other extended-release capsules or tablets. Someone switching from another methylphenidate medicine stops the old one and begins Azstarys on its own starting schedule.
The most common side effects are those typical of stimulants: reduced appetite, trouble sleeping, stomach upset or pain, nausea, weight loss, irritability, anxiety, dizziness, and a faster heart rate or higher blood pressure. Some are most noticeable in the first weeks or after a dose increase, and they may ease with a lower dose. Call the prescriber promptly about new hallucinations, unusual suspicion, or a manic state (an abnormally elevated or irritable mood with racing thoughts and little need for sleep), even in someone with no history of these problems. New or worsening tics, eye pain or changes in vision, and fingers or toes that turn pale or blue, feel cold or numb, or develop sores should also be reported. An erection that lasts too long or is painful is a rare but serious reaction to methylphenidate medicines, in adults and children, and needs emergency medical care right away, because it can require surgery to treat.
Azstarys carries the US Food and Drug Administration's (FDA) most serious warning, a boxed warning, about abuse, misuse and addiction. Stimulants can be taken in larger amounts or in unapproved ways, such as snorting or injecting, and misuse can lead to addiction, overdose and death. Prescribers assess this risk before and during treatment. The medicine should be stored securely, ideally locked, never shared, and leftover capsules disposed of properly. Azstarys is a federally controlled substance. It must not be taken with a monoamine oxidase inhibitor (MAOI), a type of medicine used mainly for depression and Parkinson's disease, or within 14 days of stopping one, because the combination can cause a dangerous spike in blood pressure. Azstarys can also blunt the effect of blood pressure medicines. Tell the surgical team before any operation, since stimulants on the day of surgery can cause sudden rises in heart rate and blood pressure under some anesthetics. Stimulants are generally avoided in people with serious heart disease, such as structural heart abnormalities, cardiomyopathy or serious heart rhythm problems, because sudden death has been reported in that group. Before starting, the prescriber asks about personal and family heart history, including sudden death. They also ask about bipolar disorder, psychosis, depression, tics or Tourette's syndrome, and glaucoma, which can be made worse. Information on use during pregnancy is limited, and anyone pregnant, planning pregnancy or breastfeeding should weigh the options with their prescriber.
The dose is reviewed and adjusted at weekly steps, so the right strength is usually settled within a few weeks. People and families commonly notice steadier attention and fewer impulsive moments through the school or work day. Because the effect is designed to last into the evening, sleep and evening appetite are worth watching. If symptoms have not improved after about a month of dose adjustments, the prescriber is likely to recommend a different approach. Follow-up visits check blood pressure and pulse, sleep, appetite and mood. In children, height and weight are tracked over time, since stimulants can slow growth; in a year-long study of Azstarys, children grew and gained weight somewhat less than expected on average. Treatment is periodically reassessed rather than continued indefinitely by default. Stopping suddenly after long use can bring temporary tiredness, low mood, vivid dreams and increased appetite, so changes are best planned with the prescriber.
Last reviewed • Oct 2026
Educational content, not medical advice.
Share your experience taking Azstarys (Serdexmethylphenidate / Dexmethylphenidate), what you've noticed, or ask the community a question.